# Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short Term

> **NCT01060618** · PHASE2,PHASE3 · COMPLETED · sponsor: **Asociacion para el Estudio de las Enfermedades Infecciosas** · enrollment: 58 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **OTHER:** Maraviroc + Trofile ESTA® (diagnose test)

## Key facts

- **NCT ID:** NCT01060618
- **Lead sponsor:** Asociacion para el Estudio de las Enfermedades Infecciosas
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2013-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060618, "Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short Term". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01060618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*